Phase 3 study of ceritinib vs chemotherapy in...

Japanese Journal of Clinical Oncology 2018 / 02

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

Kiura, Katsuyuki, Imamura, Fumio, Kagamu, Hiroshi, Matsumoto, Shingo, Hida, Toyoaki, Nakagawa, Kazuhiko, Satouchi, Miyako, Okamoto, Isamu, Takenoyama, Mitsuhiro, Fujisaka, Yasuhito, Kurata, Takayasu,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyy016
Date:
February, 2018
File:
PDF, 328 KB
english, 2018
Conversion to is in progress
Conversion to is failed